These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27037239)

  • 41. Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome.
    Takahashi H; Iwahashi N; Kirigaya J; Kataoka S; Minamimoto Y; Gohbara M; Abe T; Okada K; Matsuzawa Y; Konishi M; Maejima N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Cardiovasc Diabetol; 2018 Aug; 17(1):116. PubMed ID: 30121076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited.
    Núñez J; Garcia S; Núñez E; Bonanad C; Bodí V; Miñana G; Santas E; Escribano D; Bayes-Genis A; Pascual-Figal D; Chorro FJ; Sanchis J
    Eur Heart J Acute Cardiovasc Care; 2017 Aug; 6(5):430-440. PubMed ID: 25080512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: Insights from the ACS Israeli Survey (ACSIS) 2000-2010.
    Klempfner R; Elis A; Matezky S; Keren G; Roth A; Finkelstein A; Banai S; Goldenberg I; Fisman EZ; Tenenbaum A; Arbel Y
    Int J Cardiol; 2015 Jan; 179():546-51. PubMed ID: 25466560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus.
    Porter A; Assali AR; Zahalka A; Iakobishvili Z; Brosh D; Lev EI; Mager A; Battler A; Kornowski R; Hasdai D
    Am Heart J; 2008 Feb; 155(2):284-9. PubMed ID: 18215598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD.
    Yu C; Chen M; Chen Z; Lu G
    Herz; 2016 Nov; 41(7):605-613. PubMed ID: 26957006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
    Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
    Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognostic factors in patients with non-ST-segment elevation acute coronary syndrome concurrent with type 2 diabetes mellitus (according to the results of the registry)].
    Golikov AP; Berns SA; Stryuk RI; Shmidt EA; Golikova AA; Barbarash OL
    Ter Arkh; 2017; 89(3):65-71. PubMed ID: 28378733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inpatient- versus Outpatient-Onset Acute Coronary Syndrome: Comparison of Clinical Features and Outcomes.
    Zafar K; Patil N
    Tex Heart Inst J; 2018 Jun; 45(3):136-143. PubMed ID: 30072849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SYNTAX score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI.
    Scherff F; Vassalli G; Sürder D; Mantovani A; Corbacelli C; Pasotti E; Klersy C; Auricchio A; Moccetti T; Pedrazzini GB
    J Invasive Cardiol; 2011 Dec; 23(12):505-10. PubMed ID: 22147397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-density lipoprotein cholesterol to apolipoprotein A-1 ratio is an important indicator predicting in-hospital death in patients with acute coronary syndrome.
    Ji Z; Liu G; Zhang R; Carvalho A; Guo J; Zuo W; Zhang X; Qu Y; Lin J; Gu Z; Yao Y; Ma G
    Cardiol J; 2024; 31(2):251-260. PubMed ID: 35762073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resource utilization and outcome among patients with selective versus nonselective troponin testing.
    Campbell AR; Rodriguez AJ; Larson DM; Strauss CE; Garberich RF; Partridge MF; Henry TD; Sharkey SW
    Am Heart J; 2018 May; 199():68-74. PubMed ID: 29754668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
    Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
    J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Elbarouni B; Ismaeil N; Yan RT; Fox KA; Connelly KA; Baer C; DeYoung JP; Gallo R; Ramanathan K; Pesant Y; Leiter LA; Goodman SG; Yan AT
    Am Heart J; 2011 Aug; 162(2):347-355.e1. PubMed ID: 21835297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.
    Asano R; Kajimoto K; Oka T; Sugiura R; Okada H; Kamishima K; Hirata T; Sato N;
    Int J Cardiol; 2017 Mar; 230():585-591. PubMed ID: 28057363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
    Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
    Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome].
    Vivas D; García-Rubira JC; González-Ferrer JJ; Núñez-Gil I; del Prado N; Fernández-Ortiz A; Macaya C
    Rev Esp Cardiol; 2008 May; 61(5):458-64. PubMed ID: 18462648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycemia at admission: the metabolic echocardiography in acute coronary syndrome patients.
    Monteiro S; António N; Gonçalves F; Monteiro P; Freitas M; Providência LA
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):164-8. PubMed ID: 19293717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Long-Term Mortality in Patients Hospitalized in an Intensive Cardiac Care Unit.
    Uscinska E; Sobkowicz B; Lisowska A; Sawicki R; Dabrowska M; Szmitkowski M; Musial WJ; Tycinska AM
    Int Heart J; 2016; 57(1):67-72. PubMed ID: 26673443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial.
    de Mulder M; Umans VA; Stam F; Cornel JH; Oemrawsingh RM; Boersma E
    Diabet Med; 2011 Oct; 28(10):1168-75. PubMed ID: 21480974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of acute hyperglycaemia on the in-hospital and long-term prognosis in patients with an acute coronary syndrome--a pilot study.
    Bryniarski L; Terlecki M; Bednarek A; Kocowska M; Szynal S; Kawecka-Jaszcz K
    Kardiol Pol; 2011; 69(8):774-81. PubMed ID: 21850617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.